Gabapentin interaction with felbamate

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages 1106-

  Hussein, Gamal ^a,c   Pharm, D ^a   Troupin, Allan S ^b   Montouris, Georgia ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELBAMATE; GABAPENTIN;

ARTICLE; DRUG CLEARANCE; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG POTENTIATION; EPILEPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEADY STATE;

ACETIC ACIDS; ADULT; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DRUG INTERACTIONS; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PROPYLENE GLYCOLS;

EID: 0029826656     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.4.1106     Document Type: Article

References (5)

1. Troupin AS, Johannessen SI. Epilepsy in the elderly, a pharmacologic perspective. In: Smith DB, ed. Epilepsy: current approach to diagnosis and therapy. New York: Raven Press, 1990:141-153.
2. Graves NM. Neuropharmacology and drug interactions in clinical practice. Epilepsia 1995;36(Suppl 2):S27-S33.
3. Felbamate drug monograph. Micromedex Electronic Drug Information System, 1995.
4. Richens A. Clinical pharmacokinetics of gabapentin In: Chadwick D, ed. New trends in epilepsy management: the role of gabapentin. London: Royal Society of Medicine Services, 1993:41-46.
5. Leppik IE. Antiepileptic drugs in development: prospects for the near future. Epilepsia 1994;35(Suppl 4):S29-S40.